Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Morrow, Georgia 30260


Purpose:

The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.


Criteria:

Inclusion Criteria: - Diagnosis of dry eye syndrome Exclusion Criteria: - Intraocular or refractive surgery in the study eye within 3 months prior to study start - Unwilling to discontinue use of contact lenses during the study - Pregnancy or lactation


NCT ID:

NCT00549289


Primary Contact:

Study Chair
Roger Vogel
Sirion Therapeutics


Backup Contact:

N/A


Location Contact:

Morrow, Georgia 30260
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.